49752-95-6

Basic information

• Product Name: Butanoic acid, 3-oxo-2-[[4-[(2-pyrimidinylamino)sulfonyl]phenyl]hydrazono]-, ethyl ester
• CAS NO: 49752-95-6
• Molecular Formula: C16H17N5O5S
• Molecular Weight: 391.407
• Mol File: 49752-95-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 3-oxo-2-[[4-[(2-pyrimidinylamino)sulfonyl]phenyl]hydrazono]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 3-oxo-2-[[4-[(2-pyrimidinylamino)sulfonyl]phenyl]hydrazono]-, ethyl ester(49752-95-6)
• EPA Substance Registry System: Butanoic acid, 3-oxo-2-[[4-[(2-pyrimidinylamino)sulfonyl]phenyl]hydrazono]-, ethyl ester(49752-95-6)

Safety Data

• Hazardous Substances Data: 49752-95-6(Hazardous Substances Data)

Upstream product

• 68-35-9 sulfadiazine 
• 1723-25-7 ethyl 2,3-dioxobutyrate 
• 141-97-9 ethyl acetoacetate 
• 57198-82-0 4-(Pyrimidin-2-ylsulfamoyl)-benzenediazonium; chloride 

Downstream Products

• 49753-07-3 4-{2-[1-(2,4-dinitrophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]hydrazinyl}-N-(pyrimidin-2-yl)benzenesulfonamide 
• 52605-77-3 4-{2-[3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene]hydrazinyl}-N-(pyrimidin-2-yl)benzenesulfonamide 
• 52605-76-2 4-{2-[3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]hydrazinyl}-N-(pyrimidin-2-yl)benzenesulfonamide 
• 95914-56-0 4-[(3-methyl-5-oxo-isoxazol-4-ylidene)-hydrazino]-N-pyrimidin-2-yl-benzenesulfonamide 

Relevant articles and documents

Pyrazole and Nicotinonitrile Derivatives Synthesized from Sulfa Drugs, and Their Antibacterial Activity

Utility of sulfadiazine and sulfaguanidine in synthesis of new series of pyrazoles and 2-pyridones is described. Diazotization of sulfadiazine that results in formation of diazonium salt 2 followed by coupling of the latter with active methylene compounds

Synthesis of some New Pyrazolin-5-ones

Synthesis of some sufonamoylhydrazonopyrazolin-5-ones have been reported.

Polysubstituted pyrazoles. 1. Synthesis of 4-(4-substituted substituted sulphonamidophenylhydrazono)-2-pyrazolin-5-ones of anticipated hypoglycemic activity.

-